VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer
Abstract Background Anti-angiogenesis therapy that targets VEGF is one of the important treatment strategies in advanced ovarian cancer. However, depending on the pharmaceutical agent, treatment can have undesirable side effects. SEMA4D has recently gained interest for its role in promoting angiogen...
Main Authors: | Ying Chen, Lei Zhang, Wen-xin Liu, Ke Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Cellular & Molecular Biology Letters |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s11658-017-0058-9 |
Similar Items
-
Semaphorin SEMA3F and VEGF Have Opposing Effects on Cell Attachment and Spreading
by: Patrick Nasarre, et al.
Published: (2003-01-01) -
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
by: Minna Sopo, et al.
Published: (2019-06-01) -
Neuroimmune Semaphorin 4A in Cancer Angiogenesis and Inflammation: A Promoter or a Suppressor?
by: Apoorva S. Iyer, et al.
Published: (2018-12-01) -
Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice
by: Chao Huang, et al.
Published: (2017-07-01) -
Effect of Pomegranate peel extract on expression of angiogenesis stimulating gene (VEGF) in A2780 cell line of ovarian cancer
by: Fateme Zamani Esmati, et al.
Published: (2020-06-01)